Discovery of Antiglioma Activity of Biaryl 1,2,3,4-Tetrahydroisoquinoline Derivatives and Conformationally Flexible Analogues
Authors:
- 30 August 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (19) , 5845-5848
Abstract
Cultured rat astrocytes and C6 rat glioma were used as a differential screen for a variety of 1,2,3,4-tetrahydroisoquinoline (THI) derivatives. Compound 1 [1-(biphenyl-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrochloride] selectively blocked the growth of C6 glioma leaving normal astrocytes relatively unaffected. The potential for clinical utility of 1 was further substantiated in human gliomas and other tumor cell lines. Preliminary SAR of this activity was characterized by synthesis and testing of several THI and conformationally flexible variants.Keywords
This publication has 7 references indexed in Scilit:
- 1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for β-adrenoceptor subtypesBioorganic & Medicinal Chemistry, 2006
- Glioblastoma multiforme: The terminatorProceedings of the National Academy of Sciences, 2000
- β-Adrenoceptor Subtype Activities of Trimetoquinol Derivatives: Biochemical Studies on Human β-Adrenoceptors Expressed in Chinese Hamster Ovary CellsThe Journal of Pharmacology and Experimental Therapeutics, 1999
- 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: Novel Selective β3-Adrenoceptor AgonistsJournal of Medicinal Chemistry, 1999
- Antiproliferative action of pyrrolobenzoxazepine derivatives in cultured cells: Absence of correlation with binding to the peripheral-type benzodiazepine binding siteBiochemical Pharmacology, 1998
- Molecules Give New Insights Into Deadliest Brain CancersScience, 1997
- Astrocyte Growth, Reactivity, and the Target of the Antiproliferative Antibody, TAPAJournal of Neuroscience, 1996